Tech Company Financing Transactions
Providence Medical Technology Funding Round
Providence Medical Technology closed a $12 million financing round on 8/26/2015. Investors included Aphelion Capital, Silicon Valley Bank and Stanmore Medical Investments.
Transaction Overview
Company Name
Announced On
8/26/2015
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds will be used to further commercialize and expand its portfolio of DTRAX cervical fusion products designed to help patients suffering from cervical degenerative disc disease.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3875 Hopyard Rd. 300
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
A privately-held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market. Commercializing the DTRAX platform of minimally invasive posterior cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression and stabilization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Smith
Chief Operating Officer
Edward Liou
Vice President
Michael Scott
VP - Marketing
Scott Lynch
VP - R & D
Shigeru Tanaka
VP - Regulatory Affairs
Janie Mandrusov
VP - Sales
Jeremy Laynor
Browse more venture capital transactions:
Prev: 8/26/2015: Link Labs venture capital transaction
Next: 8/26/2015: Mobee venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs